The effect of interleukin-6 (IL-6) on cells of human megakaryocyte (MK) lineage from cord blood was explored. In semisolid colony assays containing human plasma, a greater number of both MK colonies and cells per colony was seen in the presence of IL-6 and IL-3 than in the presence of IL-3 alone. This stimulatory effect of IL-6, observed on both small and large MK colonies, was completely eliminated by the addition of anti-ll-6 antibody to the culture. IL-6 alone had no effect on MK colony formation. In the primary culture, MKs showed larger cell size and DNA content in the presence of both IL-3 and IL-6 than IL-3 alone. The replating experiments ANY CYTOKINES have been detected as a result of M the recent advances in molecular biology. It has become apparent that cytokines perform many roles, including hematopoiesis, interaction with each other to affect various types of cells, and formation of complicated networks. However, the results of in vitro and in vivo experiments using these cytokines are not always uniform and many questions remain regarding their physiological functions.
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The effect of interleukin-6 (IL-6) on cells of human megakaryocyte (MK) lineage from cord blood was explored. In semisolid colony assays containing human plasma, a greater number of both MK colonies and cells per colony was seen in the presence of IL-6 and IL-3 than in the presence of IL-3 alone. This stimulatory effect of IL-6, observed on both small and large MK colonies, was completely eliminated by the addition of anti-ll-6 antibody to the culture. IL-6 alone had no effect on MK colony formation. In the primary culture, MKs showed larger cell size and DNA content in the presence of both IL-3 and IL-6 than IL-3 alone. The replating experiments ANY CYTOKINES have been detected as a result of M the recent advances in molecular biology. It has become apparent that cytokines perform many roles, including hematopoiesis, interaction with each other to affect various types of cells, and formation of complicated networks. However, the results of in vitro and in vivo experiments using these cytokines are not always uniform and many questions remain regarding their physiological functions.
Interleukin-6 (IL-6) has been shown to act synergistically with IL-3 in the development of murine multipotential hemopoietic progenitors.'.2 Recent studies have indicated that IL-6 has a stimulatory effect on megakaryocytopoiesis in Furthermore, in vivo experiments have shown that IL-6 has thrombopoietic activity in mice' and in primates: These megakaryocytopoietic and thrombopoietic actions are of clinical importance, because they imply that IL-6 may be effective in correcting the thrombocytopenic state in humans.
In this study, we examined the effect of IL-6 on human megakaryocytopoiesis, using umbilical cord blood samples, and investigated the possibility that IL-6 plays an important role in human megakaryocytopoiesis.
MATERIALS AND METHODS

Cellpreparation.
Umbilical cord blood samples were chosen in preference to bone marrow cells because they are easy to collect and presumably contain a large number of megakaryocyte (MK) progenitor^.'^'^ Umbilical cord blood samples were aspirated into 20-mL plastic syringes coated with preservative-free heparin. Informed consent was obtained from the mothers before the experiment. Nonphagocytic mononuclear (NPMN) cells were separated by Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ) after incubation with Silica (IBL, Fujioka, Japan) for 40 minutes at 37°C. NPMN cells contained less than 2% phagocytic mononuclear cells (an estimate from nonspecific esterase staining).
Recombinant human IL-6 was synthesized by Escherichia coli expressing a cDNA for IL-6," and followed by further purification" (Ajinomoto, Kawasaki, Japan) to a specific activity of 3.6 X 106 U/mg (estimated by using the IL-6-responsive human B lymphoblastoid cell line, SKW6-CL4). Recombinant human IL-3 (Grin-Brewery, Tokyo, Japan) was produced in E coli transfected with a cDNA of proline-type IL-3, as previously reported by Otsuka et al." The specific activity of IL-3 was determined to be 6.9 X 106 Uimg by assigning 50 U to the amount stimulating half-maximal colony formation by human MK colony formation by NPMN cells was studied in methylcellulose cultures containing human plasma. One milliliter of culture mixture containing 5 x lo4 NPMN cells, a-medium (Flow Laboratories, Rockville, MD), 1% methylcellulose (Shin-etsu Chemical, Tokyo, Japan), 25% human plasma, 1% fraction V bovine serum albumin (Sigma Chemical, St Louis,
Chemicals, Rochester, NY), and various concentrations of hematopoietic factors was plated in a 35-mm Lux standard nontissue culture dish (no. 5221R; Miles Laboratories, Naperville, IL) and incubated for 12 days at 37°C in 5% CO,, 5% 0,, and 90% N,.
Plasma was collected from healthy volunteers (after informed consent) with preservative-free heparin and immediately centrifuged at 1,500 X g for 30 minutes. Platelet-poor plasma was obtained and stored at -80°C after filtration through a 0.22-pm microfilter, and filtered again before use. We chose a low-oxygen condition because it was conceivable that the viability of MKs was better in 5% CO,, 5% 0, than in 5% CO, in air. Colony types were determined by observation in situ with an inverted microscope. MK colonies were identified by their morphological characteristics as previously described.'"'' Briefly, MK colonies, which were composed of large cells having a nongranular translucent cytoplasm and a highly refractile nature, exhibited uneven cell sizes and shapes, and were scored by counting aggregates of four or more cells per colony. To confirm in situ identification of MKs, individual colonies were lifted with a 3-pL Eppendorf micropipette under direct microscopic visualization, spread on glass slides using a cytocentrifuge (Cytospin 2,
1970
IMAl ET AL Shandon Southern Instruments, Sewickley, PA), and stained by the alkaline phosphatase antialkaline phosphatase (APAAP) technique using monoclonal antibodies to human platelet/MK-specific glycoprotein (GP) IIb/IIIa complex."
Colony size was determined by direct cell counting in situ using an inverted microscope, because most of the colonies consisted of loosely arranged MKs. However, some colonies containing more than 16 cells were in tight aggregates and accurate estimation of colony size was difficult. These colonies were picked up individually and suspended in 0.2 mL a-medium. Cells were then counted by using a counting chamber.
Replating experiments. To deplete the influence of endogenous factors derived from contaminated cells in culture as much as possible, and to examine the direct effect of IL-6 on MK development, we performed replating experiments. On day 9 of incubation, MK colonies formed in the presence of 100 U/mL IL-3 were individually lifted from the culture with a 3-FL Eppendorf micropipette and pooled. After washing once, cells were resuspended in 0.5-mL liquid culture wells (Nunc, Roskilde, Denmark) containing the same concentrations of components described above, except the omission of methylcellulose. After incubating for 2 or 3 days, the cell suspension was transferred to slides with a cytocentrifuge and stained by the APAAP technique.
Individual MK size was measured by a microscope equipped with an ocular micrometer and by calculating the means of two perpendicular diameters of all GP IIb/IIIapositive cells on the slides stained by the APAAP technique.
We measured the nuclear DNA content of MKs by staining with 4',6-diamidino-2-phenylindole (DAPI, Sigma). After staining by the APAAP method, the specimens were immersed in a solution consisting of 50 ng/mL DAPI, 10 mmol/L Tris, 10 mmol/L EDTA/2 Na, 100 mmol/L NaCl, and 10 mmol/L 2-mercaptoethylamine hydrochloride (pH 7.4) and placed in a dark moist chamber for 30 minutes.",21 Nuclear DNA was measured under an epifluorescent microfluorometer (Olympus BHS-RFK and OSP-1 equipped with a 365-nm interference excitation filter, a 400-nm dichroic mirror, a 450-nm interference band-pass filter, and a x40 objective lens, Tokyo, Japan) after confirming that the cell was GP IIb/IIIa-positive. Granulocytes formed in the culture were used as diploid standards. The coefficient of variation for the 2N control cell signal was 14.6% on the average. The ploidy classes of MKs were determined by the method of Chatelain et alZ2 and Paulus et al.z)
All experiments were performed at least three times and have been shown to be reproducible. Statistical significance was determined according to Wilcoxon's rank-sum test.
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Statistical analysis.
RESULTS
First, we examined the ability of IL-6 to enhance colony growth by IL-3 in cultures containing 5 x lo4 NPMN cord blood cells. In this experiment, we used IL-6 at a concentration of 40 ng/mL, which has been shown to be the optimal concentration of IL-6 on murine MK colony formation in our previous experiment^.^ Figure 1 (P < .025). However, other types of colonies, including granulocyte, macrophage, eosinophil, granulocyte-macrophage, and granulocyte-macrophage-MK colonies were not influenced by the addition of IL-6 (data not shown).
To determine the precise role of IL-6 on MK colony formation, 5 x lo4 NPMN cells were plated in culture dishes containing 6.25 U/mL of IL-3 and various concentrations of 1L-6. MK colonies were expediently separated into two groups: those with cell numbers of less than or equal to 16 (small) and those with cell numbers greater than 16 (large). IL-6 stimulated MK colony formation in a dosedependent manner and significantly increased both small and large MK colonies (P < .05), as shown in Fig 2, with optimal stimulation at a concentration of 40 ng/mL. These observations suggest that IL-6 may augment the proliferation of different hierarchical stages of MK progenitors in the presence of IL-3. When an anti-IL-6 antibody was added to the culture containing IL-3 and IL-6, the enhancement of IL-6 on MK colony formation was completely neutralized (P < .005). The addition of anti-IL-6 antibody t o the culture with IL-3 alone decreased the number of both total colonies (P < .005) and large colonies (P < .005).
Anti-IL-6 antibody alone had no effect on MK colony formation. These findings suggest that the endogenous production of IL-6 takes part in forming MK colonies by IL-3 alone under these culture conditions.
Next, we examined the stimulatory effect of IL-6 on MK colony size in the presence of 6.25 U/mL of IL-3. The number of cells comprising individual MK colonies formed by IL-3 alone or in combination with 40 ng/mL of IL-6 or 13.3 p,g/mL of anti-IL-6 antibody (which neutralizes 40 ng/mL of IL-6) was compared. The results are presented in To examine the effect of IL-6 on MK differentiation, all MK colonies in the culture dishes containing 6.25 U/mL of IL-3 with or without 40 ng/mL of IL-6 were picked up at day 12 and spread on glass slides. The cell size and DNA content of all MKs on the specimens were measured as shown in Table 1 . The addition of IL-6 to the culture significantly increased the mean cell diameter (P < .OOOS) and the mean DNA content (P < .005) of MKs.
As it was expected that the endogenous production of IL-6 also had influence on MK differentiation in the Effect of IL-6 on MK differentiation. primary culture, the replating experiments were performed as described in Materials and Methods. The size of MKs incubated with various concentrations of IL-6 for 3 days is shown in Table 2 . MKs were on average 22.41 2 6.54 pm (mean 2 1 SD) at the outset of liquid culture. There was little change in cell size after 3 days of incubation in the absence of IL-6. This suggests that plasma prepared as described had no significant effect on MK differentiation. IL-6 significantly increased the mean cell size at concentrations of more than 4 ng/mL (P < .00005). No significant differences were seen at concentrations of IL-6 ranging from 8 to 1,000 ng/mL. Next, we examined whether IL-3 affects MK enlargement in the presence or absence of IL-6 (Table 3) . IL-3 alone failed to affect MK size. The addition of IL-3 at 1 to 1,000 U/mL to cultures containing IL-6 showed no significant increase in mean cell size in comparison with those containing IL-6 alone.
In replating experiments, the ploidy distribution of MKs was changed by the addition of IL-6 (40 ng/mL) and/or anti-IL-6 antibody (13.3 pg/mL), as shown in Table 4 . shifted the MK ploidy distribution to a larger content and significantly increased the mean ploidy (P < .00005). The stimulatory effect of IL-6 was significantly erased by the addition of anti-IL-6 antibody (P < .00005). Anti-IL-6 antibody alone had no influence on the ploidy distribution. Dose-response studies of IL-6 at concentrations ranging from 0 to 1,000 ng/mL indicated that the addition of IL-6 increased the DNA content of MKs at concentrations greater than 8 ng/mL (data not shown).
DISCUSSION
Present studies using cord blood samples demonstrated that IL-6 alone had no effect, but synergized with IL-3 to increase the number of MK colonies in a dose-dependent manner and promote an increase in the number of cells per individual MK colonies. Furthermore, the finding that anti-IL-6 antibody neutralized the stimulatory effect of IL-6 on MK colony growth suggests that IL-6 augments the Replated MKs were incubated with IL-3 and/or IL-6 for 2 days. The results represent the mean f 1 SD of pooled data from four separate experiments. *P < .00005. Replated MKs were incubated with 40 ng/mL of IL-6 and/or 13.3 bg/mL of anti-IL-6 antibody for 3 days. The results represent the mean of pooled data from three separate experiments. *P < .00005.
proliferation of human MK progenitors synergistically with IL-3. However, in this regard, several investigators have reported no significant effects of IL-6 on MK colony formation derived from human bone marrow in the presence or absence of IL-3.24*25 This discrepancy may be due to lower concentrations of IL-6 in their cultures than in ours. In contrast, Bruno and Hoffman reported that IL-6 enhances MK colony formation in the presence of a suboptimal concentration of IL-3.5 This is consistent with our results. However, they also reported that IL-6 alone increased both MK colony number and colony size. In our experiment, IL-6 alone failed to induce any MK colonies. This may be due to technical differences in cell culture methods, because they cultured normal low-density bone marrow cells in fibrin clot culture, whereas we cultured cord blood NPMN cells in methylcellulose culture.
It is of interest that the number of MK colonies and colony size formed by the combination of IL-3 and anti-IL-6 antibody were smaller than those formed by IL-3 alone. These findings suggest that IL-6 is produced endogenously by accessory cells in the culture and participates in MK colony formation by IL-3. This is supported by the report of h t e m et a1 using a murine culture ~ystem.~ During preparation of this report, Kimura et a1 reported the effect of IL-6 on human megakaryocytopoiesis.26 They explained the role of IL-6 on MK colony formation as increasing the capacity to detect the colonies by augmenting cell size and cytoplasmic maturity. However, they could not account for the variation in MK colony size by the addition of IL-6 or anti-IL-6 antibody. The idea expressed in our previous report3-that MK progenitors are supported by IL-3 in the early stage of development and require IL-6 for subsequent proliferation and differentiation-is more plausible. However, it is conceivable that many cytokines that include IL-6 are produced in the culture and interact to augment MK proliferation. To clarify whether IL-6 stimulates MK proliferation per se in concert with IL-3, further studies using single cell cultures of MK progenitors are needed.
The effects of IL-6 on murine or monkey MK differentiation have been demonstrated in ~i t r o~.~ and in vivo?8 However, the thrombopoietic activity of IL-6 on human MK differentiation remains to be elucidated. The mean cell size use only. and the mean ploidy in the primary culture containing both IL-3 and IL-6 was larger than that containing 1L-3 alone. To test whether this is a direct effect of IL-6, we performed replating experiments. The results presented in Tables 2  through 4 demonstrated that IL-6 significantly increased the mean cell size and DNA content of MKs, and that these effects were inhibited completely by the addition of anti-IL-6 antibody. However, IL-3 had no effect on MK differentiation alone or in combination with IL-6. These results suggest that IL-6 directly promotes human MK differentiation. Kimura et a1 recently reported that IL-6 increased the ploidy of cultured MKs in comparison with IL-3 in human bone marrow They cultured nonadherent BM cells with IL-6 or IL-3 independently, measured the ploidy of MKs in the culture after incubation for 8 days, and compared the ploidy distribution of those two groups. They stated that IL-6 did not augment the number of GP IIbIIIIa-positive cells. It is conceivable that MKs cultured with IL-6 alone were mainly ones that had already been contained at the start of culture; on the other hand, MKs cultured with IL-3 contained a large number of immature ones derived from MK progenitors, and those two groups are not comparable. Our studies clearly demonstrated that IL-6 increases the DNA content. However, in our experiments, many MKs were found to belong to classes of lower ploidies, rather than those present in human bone marrow. This may reflect the technical limitations of our in vitro assay system. As suggested by Sonoda et al," IL-3 supports perhaps only the early stages of development of MK progenitors, and another factor or microenvironment may be necessary for MKs to mature fully. Further studies using mature MKs are needed to clarify the effects of IL-6 on the final maturation of MKs and their production of platelets.
The optimal concentration of IL-6 for the stimulation of MK differentiation was found to be lower in comparison with the augmentation of MK proliferation, ie, MK size reached a plateau when IL-6 was present at a concentration of 8 ngImL, but the most prominent enhancement of MK colony growth supported by IL-3 was seen in the presence of at least 40 ng/mL of IL-6. These observations may be related to the results indicated by Asano et a1,8 who showed that subcutaneous injections of human IL-6 into cynomolgus monkeys at 5 Fglkgld for 14 days caused a monophasic increase in platelet counts, and at doses greater than 20 Fglkgld the increase became biphasic with a higher second peak. These results suggest that low doses of IL-6 preferentially promote MK differentiation and higher doses of IL-6 also stimulate MK proliferation.
Together with the reports indicating that IL-6 induced an increase of platelet counts during in vivo experiments using mice' and primates," the present study suggests that IL-6 may be effective in correcting the thrombocytopenic state in various hematologic disorders.
